πŸ‡ΊπŸ‡Έ FDA
Patent

US 12097262

mTORC1 inhibitors

granted A61KA61K31/436A61K31/519

Quick answer

US patent 12097262 (mTORC1 inhibitors) held by The Regents of the University of California expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/436, A61K31/519, A61K47/55, A61P